Interim results of a phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies
Issues with the kidneys, such as holding too much urine, not being able to produce enough urine, sudden kidney failure, kidney damage and inflammation, and damage to the small tubes in kidneys, are also possible, especially if your kidneys arent working properly to begin with
This is a prescription medicine consult a dermatologist before use
The study was published in JAMA Network Open
Active ingredients Sodium ascorbate 1000 mg equivalent to 889 mg vitamin C, glycerol, water, soy lecithin, rapeseed lecithin, natural flavour, pectins, citric acid
In the human clinical trial, the trajectory of weight loss became apparent during this window